MedSci专访刘伦旭教授:临床医生该如何做好科研

2015-10-20 MedSci MedSci原创

由中国抗癌协会肺癌专业委员会主办,四川大学华西医院、四川西部医药技术转移中心承办的第十四届全国肺癌学术大会于2015年10月15-17号在成都举行。本届大会紧紧围绕“关注肺癌病人生存质量,优化肺癌个体化治疗”的主题拓展学术交流的深度和广度。在大会上,梅斯医学(MedSci)有幸采访到大会秘书长刘伦旭教授。MedSci:刘教授您好,感谢您接受MedSci的采访。到今年为止,我们已经举办了十四届全国肺



由中国抗癌协会肺癌专业委员会主办,四川大学华西医院、四川西部医药技术转移中心承办的第十四届全国肺癌学术大会于2015年10月15-17号在成都举行。本届大会紧紧围绕“关注肺癌病人生存质量,优化肺癌个体化治疗”的主题拓展学术交流的深度和广度。

在大会上,梅斯医学(MedSci)有幸采访到大会秘书长刘伦旭教授。

MedSci:刘教授您好,感谢您接受MedSci的采访。到今年为止,我们已经举办了十四届全国肺癌学术大会,跟往年的大会相比,本次大会在学术力量以及规模上都有很大的提升,作为大会的秘书长,请您跟我们谈谈您个人的感想。

刘伦旭教授:今年已经是第十四届全国肺癌学术大会,不管是在学术力量以及规模上都有很大的提升,大会一直延续专业特色和学术风格,本届大会围绕“关注肺癌病人生存质量,优化肺癌个体化治疗”的主题,把个体化医学和转化医学研究、临床研究的最新成果应用于肺癌的“个体化诊断”和“个体化治疗”。全面的展示了肺癌的学术研究成果,充分的体现多学科协作的力量。

本届大会得到了来自世界各地肺癌专家,学者的大力支持,其中有1500多名国内外肺癌专家及参会代表参加了此次会议。本次大会新增加了青年优秀论文论坛,旨在让医生更加注重临床研究,促进临床研究进展,给更多的青年医生以及刚入列的医生展示自己的平台,为他们提供一个与国际接轨的平台。我们也邀请到了国内外著名专家学者进行精彩专题讲座,给予国内年轻医生建议和指导,希望年轻医生能在此获益。

MedSci:在本次大会上,很多专家也提到了精准医疗在肺癌诊治及管理上的应用,您是怎么看待的呢?

刘伦旭教授:2015年1月底,美国总统奥巴马在2015年国情咨文演讲中宣布了一个生命科学领域新项目——精准医疗计划。该计划致力于治愈癌症和糖尿病等疾病,目的是让所有人获得健康个性化信息。精准医疗更多的是遗传学分子生物角度来诊治,而个体化是更宽泛的概念,通俗说就是因人而异,因人施治。

个体化治疗的基础是药物相关的基因靶标检测,根据药物基因组学研究确定具有临床检测意义的靶标检测,通过靶标检测预测肿瘤的预后,药物的疗效和生存获益和药物毒副作用等临床指标,从而根据检测见过为医生提供更好的诊治依据。

肺癌的治疗不是简单地将治疗方法重叠使用,而是“根据患者的机体状况、免疫功能状况、肺癌的病理类型、肺癌侵犯范围和发展趋向、细胞分化程度、生物学行为、肺癌相关基因结构和功能改变,以及肺癌生物学行业和分子生物学相结合的‘个体化分子分期、分子分型’的情况。

MedSci:之前有一个很热门的话题就是“临床医生该不该做科研?”,您也跟我们谈谈您个人的想法。

刘伦旭教授:我觉得临床医生不需要做科研这是一个谬论。做科研是临床医生职责的一部分,只有通过科研,才能解决临床上的很多问题,学科才会有更好的进步,而不是只是重复以前的工作。科研并不是说一定要到实验室去做细胞,研究分子,也并没有想象的那么复杂。只要根据自己所在学科领域的临床特点,用科研的思维和研究的思维来解决临床中的问题,就会变的很容易。

所以我们要处处留心并且发现问题,回归到临床,解决问题,临床研究是伴随着医生一生的事情。

MedSci:您在学术上很有建树,也是很多杂志期刊的编委,也请您给年轻的医学工作者分享一下您发表文章的个人经验。

刘伦旭教授:文章的发表分为三大块:技术性方面的改进创新,疾病系列的总结及基础临床转化方面的研究。

对于技术性方面的改进创新,用积极的心态去接纳国际上发表过的新技术,然后总结提炼,在临床中实践。

在基础临床转化方面的研究,科研来自于临床,回归于临床,根据自己所从事领域的临床特点,在工作中不断的发现新问题,并且深入解决,这样才能写出好的文章。

MedSci:刘教授,如果方便的话,也请您跟我们介绍一下咱们团队目前开展的一些研究?

刘伦旭教授:现在我们团队在进行三方面的研究工作:

1.通过数据库:梳理过去做的研究并进行归纳总结。

2.前瞻性的研究:我们参与了肺癌局部切除前瞻性临床对照研究。

3.基础研究:目前科室很多方向,比较集中的是肺癌免疫和微环境方面的研究。

最后,祝愿我们在肺癌诊治方面能越来越受到关注,能够有更多的医生学者参与到大会,也祝愿肺癌大会能继续快速稳定的发展壮大。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 lixh1719

    公说公有理

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    呵呵

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    醉了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    呵呵

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    真是的的

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    站着说话不腰疼

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1606667, encodeId=29b1160666e94, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554752, encodeId=ca481554e528d, content=<a href='/topic/show?id=550522e2957' target=_blank style='color:#2F92EE;'>#临床医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22729, encryptionId=550522e2957, topicName=临床医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=453f14553881, createdName=xiaoyeshuang, createdTime=Thu Oct 22 09:00:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1703192, encodeId=75fc1e03192d0, content=<a href='/topic/show?id=dba720e31b7' target=_blank style='color:#2F92EE;'>#专访#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20731, encryptionId=dba720e31b7, topicName=专访)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=070a30497323, createdName=flyingeagle87, createdTime=Mon Aug 08 04:00:00 CST 2016, time=2016-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40054, encodeId=e25b40054fa, content=公说公有理, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXCR8W80NNgQuicJU3aIm3JtiaNAFLYSMlBuVfGkSlw5Z5VpmZK4PyiaDURLAorhvwhWVnaM1gQdJXA/132, createdBy=a01444383, createdName=lixh1719, createdTime=Wed Oct 21 09:12:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40033, encodeId=c3e14003356, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:17:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40029, encodeId=a2454002958, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40032, encodeId=680f4003251, content=呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40031, encodeId=08544003100, content=真是的的, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40030, encodeId=08d240030ad, content=站着说话不腰疼, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=40028, encodeId=6e0340028d5, content=醉了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85721620152, createdName=tshch, createdTime=Wed Oct 21 07:16:00 CST 2015, time=2015-10-21, status=1, ipAttribution=)]
    2015-10-21 tshch

    醉了

    0

相关资讯

Nature子刊:华人科学家发现治疗肺癌新靶点

近年来,肺癌的发病率与致死率都在不断提高,使其持续成为全球范围内最严重的癌症类型之一。其中70%-80%的患者被确诊为非小细胞癌,并且已经进入转移期。尽管目前的诊断与治疗技术已经突飞猛进,许多肺癌仍旧在后期才得以发现。鉴于非小细胞肺癌的严重性,寻找更加有效地癌症相关生物标记显得十分重要。 ID是一类抑制DNA结合/分化的转录因子,ID蛋白能够二聚化并结合调节性的E蛋白来抑制肿瘤抑制基

Lancet Oncol:高收入国家,本地居民患癌率与非本地居民不同

背景在高收入国家,本土居民相比非本土居民而言,往往身体素质更差,预期寿命更短暂。在澳大利亚、新西兰、加拿大和美国等国家,我们尚不清楚本地居民的癌症发病率及死亡率数据。此项研究旨在首次调查和比较在这些国家的本土人群的患癌率。 方式研究人员在澳大利亚的三个地区(昆士兰、西澳大利亚州、北领地)、新西兰,加拿大阿尔伯塔省和美国的卫生服务领域等地的肿瘤注册信息采集了人们罹患癌症的发生率。阿尔伯塔省第一民族和

ERS 2015:CT随访有助于提高肺癌术后患者生存率

2015年欧洲呼吸学会大会在荷兰阿姆斯特丹召开,研究人员提出,如果肺癌复发患者接受后续胸部CT检查,则他们的术后生存率会得到进一步提高。这是第一个展示肺癌患者术后接受CT追踪随访可提高总生存期限的研究,并且有利于肺癌患者的预后,并提高其生存质量。 既往研究已经证实,对肺癌切除术后的患者随访过程中进行CT检查,大多数情况下都可在患者表现复发临床表现之前监测到复发的征兆。这有助于医生尽早确立诊断,采取

NEJM:治疗小细胞肺癌的新武器——Nivolumab

对患有非小细胞癌且肿瘤进展、使用化疗药无效的患者来说,医生采取的治疗方案极为有限且效果不佳。但是,一项新的试验发现,一种名为Nivolumab的药物可以改善这些患者的生存状况并提高其生存率。 这项研究发表在The New England Journal of Medicine ,且于近日在奥地利维也纳举行的欧洲癌症大会上提出。据美国癌症协会(ACS)统计,约85-90%的肺癌病例患者为非小细胞肺癌

吴一龙教授:肺癌的临床试验和真实世界研究

由中国抗癌协会肺癌专业委员会主办,四川大学华西医院、四川西部医药技术转移中心承办的第十四届全国肺癌学术大会于2015年10月15-17号在成都举行。本届大会紧紧围绕“关注肺癌病人生存质量,优化肺癌个体化治疗”的主题拓展学术交流的深度和广度。在大会上,来自广东省人民医院/广东省肺癌研究所的肺癌专家吴一龙教授分享了“肺癌的临床试验和真实世界研究”。记得吴一龙教授在参加第16届世界肺癌大会(WCLC)中

陆舜教授:肺癌新分期修订方案解读

在成都举行的第十四届全国肺癌学术大会,来自上海肺部肿瘤临床医学中心/上海交通大学附属胸科医院的陆舜教授分享了“肺癌新分期修订方案解读”。第八版数据来源(图)此次改版内容1,更多的是与肿瘤大小相关2,重新定义了某些T的指标3,确认了目前N的定义标准4,确认了一些关于转移结节数量5,转移组分为了3组6,增加了分期,可以更好的预计患者的预后治疗模式研究人群研究结果T分期调整:肿瘤大小,累及主支气管,肺不